Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Library Health Topics Collection Guidelines Optimal therapy recommendations for the prescribing and use of second-line therapy for patients with diabetes inadequately controlled on metformin. Canadian Agency for Drugs and Technologies in Health. NGC:008154
Document Actions

Optimal therapy recommendations for the prescribing and use of second-line therapy for patients with diabetes inadequately controlled on metformin. Canadian Agency for Drugs and Technologies in Health. NGC:008154

Publication Details
Author(s):
  • AHRQ (US) - Agency for Healthcare Research and Quality
Country(ies) of application:
  • Canada
Language(s):
  • English
Type of Publication:
Guideline Clearing Report
Primary Contact:
Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov
Publication URL:
Open Publication URL in a new window
Publication Scope:
  • Assessment/diagnosis
  • Management
Publication Status:
Published
Date of publication:
Aug 01, 2010
Due for Review:
-
Diseases / Conditions Addressed
MeSH Terms addressed:
  • Endocrine System Diseases (C19)
    • Diabetes Mellitus (C19.246)
      • Diabetes Mellitus, Type II (C19.246.300)
  • Nursing (G02.478)
  • Therapeutics (E02)
  • Pharmacologic Actions (D27.505)
Guideline key questions
Page last updated: Jun 06, 2011

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.